RBCK1 regulates the progression of ER-positive breast cancer through the HIF1α signaling
Abstract Breast cancer is the most common malignancy in women on a global scale. It can generally be divided into four main categories, of which estrogen receptor ER-positive breast cancer accounts for most breast cancer cases. RBCK1 protein is an E3 ubiquitin ligase containing the UBL, NZF, and RBR...
Main Authors: | Zhiguo Niu, Jianing Fan, Fengzhe Chen, Huijie Yang, Xin Li, Ting Zhuang, Chunlei Guo, Qi Cao, Jian Zhu, Hui Wang, Qingsong Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2022-12-01
|
Series: | Cell Death and Disease |
Online Access: | https://doi.org/10.1038/s41419-022-05473-6 |
Similar Items
-
RBCK1 is an endogenous inhibitor for triple negative breast cancer via hippo/YAP axis
by: Zhongbo Li, et al.
Published: (2022-10-01) -
Expanding the phenotype of RBCK1-associated polyglucosan body myopathy type 1
by: Manuel Pühringer, et al.
Published: (2024-03-01) -
Corrigendum to “Expanding the phenotype of RBCK1-associated polyglucosan body myopathy type 1”
by: Manuel Pühringer, et al.
Published: (2024-03-01) -
RBCK1 promotes hepatocellular carcinoma metastasis and growth by stabilizing RNF31
by: Xijun Chen, et al.
Published: (2022-07-01) -
ZNF213 Facilitates ER Alpha Signaling in Breast Cancer Cells
by: Huijie Yang, et al.
Published: (2021-03-01)